Sales of Embolotherapy is projected to top a valuation of USD 7.7 billion forecast 2021-2031 | Boston Scientific Corporation, Merit Medical Systems

The global Embolotherapy market was valued at USD 3.8 billion in 2021 and it is anticipated to grow up to USD 7.7 billion by 2031, at a CAGR of 7.3% during the forecast period.

Embolotherapy is the process of obstructing arteries with a device (such as a balloon catheter) in order to treat or stop uncontrollable bleeding. Utilizing this technique, tumors are reduced, and bleeding is controlled. It is an endovascular procedure that attempts to stop bleeding by restricting aberrant blood arteries. Embolotherapy is mostly used to treat cervical uprooted pregnancy, postpartum situations, and pelvic tract hemorrhage.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample –

This treatment has shown promise in the management of iatrogenic solid organ, vascular, and non-operative organ damage, including lesions to the liver, spleen, and kidneys. Embolotherapy is used to treat enlarged uterine fibroids, de vascularize tissues and organs prior to surgery, and eliminate duodenal varices. This necessitates choosing an embolization agent with the required level of vascular blockage permanence.

Market Drivers and Trends

Because more target procedures are being performed on more target patients, the market for embolotherapy devices has been rising steadily over the past ten years. CVD is a major target illness, and research on successful and efficient treatments has focused on it because of its significance and high prevalence. Globally, more than 200 million people have peripheral vascular disorders as of 2017. The prevalence of these disorders increases with age, with the over-80 age group showing a prevalence rate of more than 20%.

The market for embolotherapy devices will likely increase in the near future due to the high success rate and low postoperative complication rate associated with embolotherapy procedures as well as the rising prevalence of liver cancer and hepatocellular carcinoma. The fifth most prevalent cancer in males and the ninth most common in women is liver cancer. Over 840,000 new cases were diagnosed globally in 2018. World Cancer Research Fund, a source. In addition, incidence rates of kidney cancer rose by 42% in the UK over the previous ten years. Male incidence rates were 38 percent, compared to a 44 percent increase in female incidence rates.

Get A Customized Scope to Match, Your Need Ask an Expert –

Market Segments

By Product

  • Embolization Coil
  • Embolic Agents
  • Detachable Balloons
  • Embolic Plug Syndrome
  • Support Devices

By Application

  • Oncology
  • Peripheral Vascular Diseases
  • Urology & Nephrology
  • Neurology
  • GIT Disorders

By Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

For In-Depth Competitive Analysis, Purchase this Report –

Major Players in the Global Embolotherapy Market

The key players studied in the global embolotherapy market are Boston Scientific Corporation (US), Merit Medical Systems (US), Terumo Corporation (Japan), Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), BTG plc (UK), Penumbra, Inc. (US), Cook Medical (US), Abbott Laboratories (US), Acandis GmbH (Germany), BALT Extrusion (France), Sirtex Medical Limited (Australia), Kaneka Corporation (Japan), and Meril Life Sciences Pvt. Ltd. (India).

New Report Published by Global Insight Services:

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700